Showing results (11-20 of 128) with videos related to
Sort By:
Pageof 13
Acta Pharmacologica Et Toxicologica|September 1, 1978
Enhancement of urine prostaglandin excretion by chlorazanil in dogsU B Olsen, I Ahnfelt-RønneBiochemical Pharmacology|July 15, 1989
Inhibition by the LTD4 antagonist, SR2640, of effects of LTD4 on canine polymorphonuclear leukocyte functionsM K Thomsen, I Ahnfelt-RønneUgeskrift for Laeger|April 17, 1989
[Inflammation and free oxygen radicals]O H Nielsen, I Ahnfelt-RønneUgeskrift for Laeger|January 14, 1991
[Leukotrienes. A review of the significance for disease in man and the possibilities for therapeutic intervention]M K Thomsen, I Ahnfelt-RønnePharmacology & Toxicology|April 1, 1988
4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazylO H Nielsen, I Ahnfelt-RønneBiochemical Pharmacology|September 1, 1985
Leukotriene production in rat peritoneal leukocytes requires intact energy metabolismI Ahnfelt-Rønne, U B OlsenArchives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 16, 1998
[New growth hormone secretagogues: from physiology to the first therapeutic applications]I Ahnfelt-Rønne, P M HaahrKlinische Wochenschrift|December 15, 1991
Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel diseaseO H Nielsen, I Ahnfelt-RønneAgents and Actions|June 1, 1987
The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavengerI Ahnfelt-Rønne, O H NielsenEuropean Journal of Pharmacology|October 11, 1988
A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid)I Ahnfelt-Rønne, D Kirstein, C Kaergaard-NielsenPageof 13